HDAC9 and breast carcinoma: In a more recent study, Βhura and colleagues performed the molecular docking assay for basil polysaccharides, in order to find out the binding potential against different epigenetic targets of breast cancer, including histone deacetylases (HDAC), HDAC1-2, 4–8, and histone acetyltransferases (HAT).